Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., . . . Schwartz, J. D. (2008). Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. Journal of clinical oncology, 26(18), 2992. https://doi.org/10.1200/JCO.2007.15.9947
Citácia podle Chicago (17th ed.)Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology 26, no. 18 (2008): 2992. https://doi.org/10.1200/JCO.2007.15.9947.
Citácia podľa MLA (8th ed.)Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology, vol. 26, no. 18, 2008, p. 2992, https://doi.org/10.1200/JCO.2007.15.9947.